Akero Therapeutics
AKRO54.6500.00% ( 0.000 )
Forecast & Rating7 analysts currently cover Akero Therapeutics, with about 14.3% giving a positive rating — meaning they expect the stock to rise. For you, this means most institutions are cautious on Akero Therapeutics's outlook. Data as of Dec 8, 2025; for reference only and not investment advice.
Nov 13, 2025Price forecast
--100.00%
Forecast & RatingHold
7analysts
- Strong buy14.29%
- Buy0.00%
- Hold85.71%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineDec 7, 2025
Forecast met0.0%
Stock price$54.65
Average forecast price$0.0
Highest forecast price$58
Lowest forecast price$54
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.